Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Lexagene Holdings Inc LXXGQ

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in... see more

GREY:LXXGQ - Post Discussion

Lexagene Holdings Inc > LXG's technology needed more than ever for Covid-19
View:
Post by TanzaniteMotherLode on May 16, 2020 10:48am

LXG's technology needed more than ever for Covid-19

Scientists concerned that coronavirus is adapting to humans:

Scientists have found evidence for mutations in some strains of the coronavirus that suggest the pathogen may be adapting to humans after spilling over from bats.


The analysis of more than 5,300 coronavirus genomes from 62 countries shows that while the virus is fairly stable, some have gained mutations, including two genetic changes that alter the critical “spike protein” the virus uses to infect human cells.

The spike mutations are rare at the moment but Martin Hibberd, professor of emerging infectious diseases and a senior author on the study, said their emergence highlights the need for global surveillance of the virus so that more worrying changes are picked up fast.

https://www.msn.com/en-ca/health/medical/scientists-concerned-that-coronavirus-is-adapting-to-humans/ar-BB13TeEi?li=BBXLjO0
 

Advertisement
Comment by letsdoit on May 16, 2020 1:27pm
problem is though (not sure if you haven't noticed?) but Lexagene haven't got anything to sell right now and I've been told they have put launch date back to 2035
Comment by Investor62 on May 16, 2020 2:49pm
give a proof for "and I've been told they have put launch date back to 2035" otherwise please stay away from the board and don't spread nonsense
Comment by letsdoit on May 16, 2020 3:36pm
Sorry my mistake it was a typo error, 2021 I meant to write, my mistake
Comment by ragb7002 on May 16, 2020 5:44pm
Wow 2035. Do you know what month?
Comment by letsdoit on May 16, 2020 6:06pm
Comment by letsdoit on May 16, 2020 6:08pm
not sure to be honest rag LOL
Comment by Investor62 on May 17, 2020 4:43am
@letsdoit: it would be desirable if you would substantiate your statements! On what assumption do you assume that production will not start until 2021? A reply like: “not sure to be honest rag LOL» another post, which neither passes on sound knowledge nor gives away any relevant information about the company – waste of time!   In the last available press release (April 16, 2020), Dr Jack ...more  
Comment by ragb7002 on May 17, 2020 11:47am
And I have a nice bridge for you!!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities